Insulet Corporation at Wells Fargo Healthcare Conference Transcript
All right, welcome back. I'm Larry Biegelson, the Medical Device Analyst at Wells Fargo, and it's my pleasure to host this fireside chat with the management team from Insulate.
With us, we have Ashley McAvoy, President and CEO and Flavia Pease, Executive Vice President and CFO and Claire Trachman, Head of Investor Relations.
Ashley and Flavia, thanks so much for being here.
Questions & Answers
So, Ashley, it's hard not to start with the Q2 updates or update. So let's start there.
You took down guidance because of three issues, lower retention and utilization in Type 2, lower new starts due to softness in Q1 and less pricing. Two-thirds of the change was due to the Type 2 issue. And probably the number one question we've been getting, and my guess is you, why was this such a surprise?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
